PET/MR scan for Crohn's disease scar tissue
Treatments studied
Part of Digestive system clinical trials.
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have Crohn's disease, either confirmed by a biopsy or strongly suspected by your doctor.
- You are able to understand and sign a consent form to participate.
- You do not have any metal implants, pacemakers, or other devices that are not safe for MRI.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to a pregnancy test.
- You are not severely claustrophobic and can lie still in the scanner for the exam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Crohn’s disease affects bones and bone marrow soon after diagnosis. It may help researchers understand disease effects and improve future care, either by comparing you to healthy controls or by tracking changes over time.
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
This study uses a special PET-MRI scan to look at inflammation and blood flow in the small intestine of people with Crohn's disease. It may help doctors better understand disease activity in the gut.
This study looks at how Crohn’s disease healing shows up on a special MRI (MRE) and tries to better define what “healed” means. It may help your care team track healing more accurately, especially inside the bowel.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This trial compares two types of scans—MRI and ultrasound—to see how well they detect changes in Crohn's disease after treatment. If you've had one of these scans already and need another to check your response to therapy, you may be able to join.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.